← Leaderboards
Stanley Hsia
Charles R. Drew University Of Med &Sci
$3,105,136
Attributed
$3,105,136
Total exposure
14
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $862.2K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,105,136 · 14
By mechanism
U54$1,676,000 · 9
P20$998,636 · 4
SC3$430,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Charles R. Drew University Of Med &Sci
Same institution · by research overlap
- Indrani Sinha-Hikim$549,744
- Karen Louise Herbst$1,689,937
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingInsulin SensitivitySourceInsulinUnited States National Institutes Of HealthGrantResourcesClinical TrialsInstitutionResearch PersonnelComputer Retrieval Of Information On Scientific Projects DatabaseBody CompositionCounselingOutcome MeasureProgramsAerobic ExerciseCareerLow IncomeDoseProtocols DocumentationRandomizedExerciseAffectBody Weight
Grant awards (17)
Pilot Study of the Efficacy of Mifepristone in Males with Type 2 Diabetes Mellitu$107,625
SC3 · FY2019 · GM · contact PI
Pilot Study of the Efficacy of Mifepristone in Males with Type 2 Diabetes Mellitu$107,625
SC3 · FY2018 · GM · contact PI
Pilot Study of the Efficacy of Mifepristone in Males with Type 2 Diabetes Mellitu$107,625
SC3 · FY2017 · GM · contact PI
Pilot Study of the Efficacy of Mifepristone in Males with Type 2 Diabetes Mellitu$107,625
SC3 · FY2016 · GM · contact PI
INSULIN RESISTANCE IN SMOKERS UNDERGOING SMOKING CESSATION$36,404
U54 · FY2011 · RR · contact PI
CLINICAL TRIAL: DANCE DANCE REVOLUTION (DDR)$36,404
U54 · FY2011 · RR · contact PI
CLINICAL TRIAL: DANCE DANCE REVOLUTION (DDR)$41,822
U54 · FY2010 · RR · contact PI
INSULIN RESISTANCE IN SMOKERS UNDERGOING SMOKING CESSATION$41,822
U54 · FY2010 · RR · contact PI
AEROBIC EXERCISE ON INSULIN SENSITVITY, METABOLIC SYNDROME$55,443
U54 · FY2009 · RR · contact PI
CLINICAL TRIAL: INTENSITIES OF AEROBIC EXERCISE VS ROSIGLITAZONE ON INSULIN$1,597
P20 · FY2009 · RR · contact PI
CLINICAL TRIAL: EFFECTS OF AEROBIC EXERCISE ON INSULIN SENSITIVITY AND THE METAB$267,972
U54 · FY2008 · RR · contact PI
CLINICAL TRIAL: INTENSITIES OF AEROBIC EXERCISE VS ROSIGLITAZONE ON INSULIN$19,164
P20 · FY2008 · RR · contact PI
HORMONE ASSAY CORE$485,118
P20 · FY2007 · RR · contact PI
EFFECTS OF AEROBIC EXERCISE ON INSULIN SENSITIVITY AND THE METABOLIC SYNDROME$377,043
U54 · FY2007 · RR · contact PI
HORMONE ASSAY CORE$492,757
P20 · FY2006 · RR · contact PI
EFFECTS OF AEROBIC EXERCISE ON INSULIN SENSITIVITY AND THE METABOLIC SYNDROME$316,947
U54 · FY2006 · RR · contact PI
PILOT 1-EFFECTS OF EXERCISE ON INSULIN SENSITIVITY AND METABOLIC SYNDROME$502,143
U54 · FY2005 · RR